DK727488A - Benzimidazolderivater og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse - Google Patents

Benzimidazolderivater og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse

Info

Publication number
DK727488A
DK727488A DK727488A DK727488A DK727488A DK 727488 A DK727488 A DK 727488A DK 727488 A DK727488 A DK 727488A DK 727488 A DK727488 A DK 727488A DK 727488 A DK727488 A DK 727488A
Authority
DK
Denmark
Prior art keywords
group
carbon atoms
preparation
application
represents hydrogen
Prior art date
Application number
DK727488A
Other languages
Danish (da)
English (en)
Other versions
DK727488D0 (da
Inventor
Endre Palosi
Dezso Korbonits
Erzsebet Molnar
Ida Szvoboda
Laszlo Harsing
Gyoergy Simon
Sandor Virag
Vera Gergely
Katalin Marmarosi
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of DK727488D0 publication Critical patent/DK727488D0/da
Publication of DK727488A publication Critical patent/DK727488A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/22—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK727488A 1987-12-30 1988-12-29 Benzimidazolderivater og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse DK727488A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU876131A HU207051B (en) 1987-12-30 1987-12-30 Process for producing 4-chloro-3-sulfamoylbenzoic acid hydrazides and pharmaceutical compositions comprising such compounds

Publications (2)

Publication Number Publication Date
DK727488D0 DK727488D0 (da) 1988-12-29
DK727488A true DK727488A (da) 1989-07-01

Family

ID=10971250

Family Applications (1)

Application Number Title Priority Date Filing Date
DK727488A DK727488A (da) 1987-12-30 1988-12-29 Benzimidazolderivater og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse

Country Status (27)

Country Link
US (1) US4916149A (cs)
EP (1) EP0324988B1 (cs)
JP (1) JPH01213269A (cs)
CN (1) CN1037336A (cs)
AT (1) ATE75467T1 (cs)
AU (1) AU609682B2 (cs)
CA (1) CA1332739C (cs)
CS (1) CS277585B6 (cs)
DD (1) DD283383A5 (cs)
DE (1) DE3870601D1 (cs)
DK (1) DK727488A (cs)
ES (1) ES2034149T3 (cs)
FI (1) FI886045A7 (cs)
GR (1) GR3004471T3 (cs)
HU (1) HU207051B (cs)
IE (1) IE63246B1 (cs)
IL (1) IL88735A (cs)
NO (1) NO172285C (cs)
NZ (1) NZ227481A (cs)
PH (1) PH25739A (cs)
PL (2) PL157971B1 (cs)
PT (1) PT89368B (cs)
RU (2) RU1838303C (cs)
SU (1) SU1736339A3 (cs)
UA (1) UA19123A (cs)
YU (1) YU47125B (cs)
ZA (1) ZA889729B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2104938T3 (es) * 1991-04-01 1997-10-16 Univ Duke Metodo de inhibir la fibrosis.
FR2708608B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
DE10132896A1 (de) * 2001-07-06 2003-01-16 Bayer Cropscience Ag Heterocyclische Amidderivate
DE102005002130A1 (de) * 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1122541B (de) * 1959-12-28 1962-01-25 Hoechst Ag Verfahren zur Herstellung von Sulfamyl-anthranilsaeuren
DE1158927B (de) * 1961-09-15 1963-12-12 Werner Rahms Grubenstempel
DE2144908C2 (de) * 1971-09-08 1982-12-09 Hoechst Ag, 6000 Frankfurt 5-(3- oder 4-Aminobenzolsulfonylamino)-benzimidazolone-(2) und Verfahren zu ihrer Herstellung
BE793718A (fr) * 1972-01-07 1973-07-05 Merck & Co Inc Aminobenzimidazoles
DE2247828A1 (de) * 1972-09-29 1974-04-04 Hoechst Ag Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung
US4420487A (en) * 1978-04-10 1983-12-13 The Purdue Frederick Company Diuretic and antihypertensive benzimidazoles

Also Published As

Publication number Publication date
EP0324988B1 (de) 1992-04-29
US4916149A (en) 1990-04-10
DE3870601D1 (de) 1992-06-04
IL88735A (en) 1992-12-01
NO172285B (no) 1993-03-22
UA19123A (uk) 1997-12-25
IL88735A0 (en) 1989-07-31
DD283383A5 (de) 1990-10-10
HU207051B (en) 1993-03-01
RU1838303C (ru) 1993-08-30
CA1332739C (en) 1994-10-25
RU1830064C (ru) 1993-07-23
DK727488D0 (da) 1988-12-29
PL158049B1 (pl) 1992-07-31
SU1736339A3 (ru) 1992-05-23
NZ227481A (en) 1990-11-27
JPH01213269A (ja) 1989-08-28
YU47125B (sh) 1994-12-28
IE63246B1 (en) 1995-04-05
PT89368B (pt) 1993-08-31
CN1037336A (zh) 1989-11-22
CS277585B6 (en) 1993-03-17
NO885830L (no) 1989-07-03
ES2034149T3 (es) 1993-04-01
AU609682B2 (en) 1991-05-02
NO172285C (no) 1993-06-30
EP0324988A1 (de) 1989-07-26
PH25739A (en) 1991-10-18
FI886045A7 (fi) 1989-07-01
PL157971B1 (pl) 1992-07-31
NO885830D0 (no) 1988-12-30
PL276889A1 (en) 1990-04-02
GR3004471T3 (cs) 1993-03-31
HUT56550A (en) 1991-09-30
PT89368A (pt) 1989-12-29
IE883892L (en) 1989-06-30
AU2763188A (en) 1989-07-13
ATE75467T1 (de) 1992-05-15
CS910888A3 (en) 1992-09-16
ZA889729B (en) 1989-10-25
YU240188A (en) 1990-10-31

Similar Documents

Publication Publication Date Title
NO941592L (no) Adhesjonsreseptorantagonister
NO922147L (no) Heterocykliske derivater
IL113011A (en) R-mandelic acid salt of (2s,3s)-3- (2-methoxybenzylamino)-2- phenylpiperidine
AU9281198A (en) Benzofuran derivatives
DK240084D0 (da) New beta-carboline-3-oxadiazolyl derivatives
DK0466137T3 (da) Salte af triazinderivater med oxygenerede syrer af phosphor og deres anvendelse i selvslukkende polymersammensætninger
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
BR9916324A (pt) 4,5-pirazinoxindóis como inibidores de proteìna quinase
DK727488D0 (da) Benzimidazolderivater og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DE3771143D1 (de) Benzothiazepin-vasodilatoren mit aralkylsubstitution.
KR860001808A (ko) 이미다조〔1,5-a〕피리미딘 유도체의 제조방법
NO871575D0 (no) Fremgangsmaate for fremstilling av 1,5-benztiazepinderivater.
ATE92070T1 (de) Azachromanderivate.
ZA893766B (en) Thienylpiperazinones,their preparation and their use
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
FI971177A0 (fi) Bisyklisiä karboksiamideja 5-HT1A-antagonisteina
DK0527314T3 (da) Fremgangsmåde til fremstilling af 2-aryl-2H-1,2,3-triazoler
FI904033A0 (fi) Nya 1,3-oxaziner.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment